TurnCareâ„¢ Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • TurnCareâ„¢'s estimated annual revenue is currently $10M per year.(i)
  • TurnCareâ„¢'s estimated revenue per employee is $251,000

Employee Data

  • TurnCareâ„¢ has 40 Employees.(i)
  • TurnCareâ„¢ grew their employee count by 5% last year.

TurnCareâ„¢'s People

NameTitleEmail/Phone
1
CEO, Co-FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Senior Director, EngineeringReveal Email/Phone
4
Senior Clinical Director, ConsultingReveal Email/Phone
5
Sales ManagerReveal Email/Phone
6
Senior Product Marketing ManagerReveal Email/Phone
7
Clinical Product ManagerReveal Email/Phone
8
Manager Clinical Team: Customer Success and Inventory SpecialistReveal Email/Phone
9
Manager Clinical Implementation ServicesReveal Email/Phone
10
Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is TurnCareâ„¢?

Our mission at TurnCare is protect the high-acuity patient. Our Story: TurnCare was founded in 2011 by Dr. Rafael Squitieri, Chief of Cardiothoracic Surgery at St. Vincent’s Medical Center in Bridgeport, CT, along with Kim Orumchian, serial entrepreneur and technology expert. Dr. Squitieri was frustrated by the number of patients developing complications due to sacral-region ischemia / reperfusion injury, despite clinicians’ best manual efforts to maintain adequate perfusion and use of the latest therapeutic equipment. Dr. Squitieri focused on the circulatory system’s critical role in health to create a technology that would prevent sacral-region vascular compromise to enhance perfusion to sacral-region tissues and mitigate the harmful effects of I/R injury. After four years of painstaking research and hundreds of prototypes, Dr. Squitieri and his interdisciplinary team developed the TurnCare Guardian System, which was shown in a 399-patient randomized, controlled trial to reduce sacral-region hospital-acquired pressure injuries by 81%. Due to the system’s unique technology and ability to prevent ischemia / reperfusion injury, it has also been found to have unexpected and profound benefits. Additional findings suggest that the TurnCare Guardian System can have a significant positive impact on the recovery of high-acuity, mobility-impaired patients. Contact: TurnCare, Inc. 2225 E. Bayshore Road, Suite 200 Palo Alto, California (203) 437-6768 turncare.com info@turncare.com

keywords:N/A

N/A

Total Funding

40

Number of Employees

$10M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M4011%N/A
#2
$4.6M4011%N/A
#3
$4.5M4018%N/A
#4
$4.4M405%$30.3M
#5
$4.6M4025%N/A